A Real-World Study of Mirvetuximab Soravtansine (MIRV) in Ovarian Cancer Patients of Expression of Folate Receptor α
1d agoen
From the article
Conditions : Ovarian Cancer; Fallopian Tube Cancers; Primary Peritoneal Cancer Interventions : Drug: Mirvetuximab Soravtansine (MIRV) Sponsors : NING LI-GYN Not yet recruiting
Continue reading on clinicaltrials.govYou might also wanna read
Ovarian cancer drug mirvetuximab improves quality of life for patients, UK women report
A new ovarian cancer drug called mirvetuximab is offering women more time and a better quality of life compared to standard chemotherapy. Pa
bbc.co.uk·1mo ago
Una nueva terapia logra atacar el cáncer de ovario reduciendo el daño a las células sanas
Infobae·2d ago
Real-World EV Plus Pembro Success Seen in Urothelial Cancer
Medscape·20h ago
https://doi.org/10.1056/NEJMoa2517384
doi.org·1mo ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.